NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)

Clinical trial NCT05529940 · RECRUITING

Trial details

NCT number: NCT05529940
Sponsor: Seoul National University Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Resectable Pancreatic Cancer Neoadjuvant Chemotherapy Effects of Chemotherapy

Start date: 2023-04-01
Primary completion: 2024-12-01
Enrollment: 609

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.